Related Experiment Video
Updated: Aug 16, 2025

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.2K
Functional outcomes after prostate cancer treatment: A comparison between single and multiple modalities
Alexandra Muise1, Michael M Pan2, Brent Rose3
1University of California San Diego School of Medicine, San Diego, CA.
Urologic Oncology
|December 19, 2022
Summary
Treatments for prostate cancer impact quality of life. Radiation therapy (RT) alone has fewer side effects than radical prostatectomy (RP) alone, but combination therapies increase risks, especially RT followed by RP.
Area of Science:
- Urology
- Oncology
- Medical Outcomes Research
Background:
- Prostate cancer treatments significantly affect survivors' quality of life due to functional side effects.
- Understanding the comparative rates of these side effects across different treatment modalities is crucial for patient counseling and care.
Purpose of the Study:
- To compare the rates of diagnosis and treatment of common functional side effects following prostate cancer treatment with radical prostatectomy (RP)-only, radiation therapy (RT)-only, or combined modalities.
- To evaluate the impact of treatment sequencing on functional outcomes.
Main Methods:
- Retrospective review of the SEER-Medicare database (2004-2013).
- Analysis of 67,527 patients undergoing prostate cancer treatment.
- Comparison of functional outcomes including erectile dysfunction, urinary incontinence (UI), urethral stricture, cystitis, and proctitis.
Main Results:
- RT-only was associated with lower rates of erectile dysfunction and UI compared to RP-only.
- RT-only had higher rates of urethral stricture, cystitis, and proctitis than RP-only.
- Combined modality treatments, particularly RP then RT, showed higher rates of incontinence and stricture therapy.
- RT followed by RP (RT-then-RP) demonstrated the highest rates of stricture and fistula treatment.
Conclusions:
- Multimodality therapy for prostate cancer, especially in patients over 65, is linked to higher treatment rates for adverse functional outcomes.
- Radiation therapy followed by radical prostatectomy is associated with significantly worse functional outcomes.
- Patients should be informed about the increased risk of declining functional outcomes with multimodality treatment approaches.
Related Concept Videos
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer Survival Analysis
413
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
413
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K

